Chapter 521
Chapter 521
At that time, these pharmaceutical companies can also blame their respective countries for not having such a strong medical insurance as China, and completely shift the responsibility for sky-high drug prices. Then they can continue to sell high-priced drugs.
And at this time,
Anna's cell phone also rang. It was an international long-distance call.
When she saw the number clearly, Anna couldn't help but smile.
Luo Shiyun called.
The other party calling at this time means that the cooperation she has been thinking about should have come to fruition.
"Hello, Mr. Luo!"
"Regarding overseas agency, I certainly hope to cooperate with your company."
"As for Antai Pharmaceutical Group's offer, we can accept it. As for the profit, I think it should be fine."
After answering the call immediately,
Anna quickly confirmed that her guess was correct.
Luo Shiyun called at this time, indeed for overseas agency cooperation on the special medicine for lung cancer.
Anna has been eager for this agency cooperation.
After a brief thought, she readily agreed to the conditions proposed by Luo Shiyun.
The factory price of 2 is not excessive at all.
The only thing that made her hesitate was that the profit could only be around 10% and she couldn't increase the price too much.
This controlled Novartis's opportunity to make huge profits, which inevitably made her hesitate, but she finally agreed.
With a profit of about 10%, you can earn about 2000 yuan. Adding taxes and other fees, the actual retail price is estimated to be 25000 yuan.
However, the profit from Novartis's agency of this drug is secondary. The real purpose is to use it to enhance its own global influence. Therefore, it can be done even if the profit is low.
The most important thing is that the lung cancer specific drug is basically a best-selling drug that is guaranteed to make a profit. Even if the profit is low, it is a good business that is guaranteed to make a profit regardless of the market conditions. She has no reason to refuse.
As long as you can get this agency contract, you can make back the money elsewhere, and it will definitely not be a losing business.
Moreover, the lung cancer drug is so popular, if we can get the agency rights,
Then her status in Luohua will naturally rise, and she is very sincere in promoting this cooperation.
"It's done, it's finally done."
"My previous efforts were not in vain. I finally gained Chen Xuan's friendship."
"For this collaboration, I must lead the Novartis side. I can't let anyone else snatch it away."
After hanging up the phone, Anna couldn't help but get excited.
She felt that her sincerity during this period had finally paid off.
If she hadn't been actively showing goodwill, Chen Xuan wouldn't have thought of cooperating with her in the first place.
Lung cancer drugs are now in great demand. The fact that Novartis can directly obtain the agency rights can only mean that the previous cooperation and her goodwill played a role.
If it weren’t for the previous cooperation, I’m afraid we might not be able to compete with other pharmaceutical companies this time.
Anna was the first person to think of taking the lead in this project.
Novartis must take responsibility for itself so that it can make its own contribution and cannot let others reap the benefits for nothing.
She was also worried that someone else would mess things up.
"President, Pfizer is researching a pharmaceutical company."
"Based on the current information, Pfizer is very likely to acquire this pharmaceutical company."
"This is all the information about this pharmaceutical company. They've developed an anti-cancer drug, which is likely to become a blockbuster product in the future."
At this time, her assistant delivered an investigation report.
Pfizer and Novartis are also competitors, so they will naturally keep an eye on each other's actions.
If you don't monitor your competitors' every move, you might be foolishly unaware when they swallow you up.
mtl008